2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Leukemia, Myeloid, Acute in 4 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Geng, Y | 2 |
Wu, W | 1 |
Zhou, L | 1 |
Li, J | 1 |
Yang, Y | 1 |
Huang, FF | 1 |
Wu, DS | 1 |
Zhang, L | 1 |
Yu, YH | 1 |
Yuan, XY | 1 |
Li, WJ | 1 |
Chen, XP | 1 |
Zhao, XL | 1 |
Chen, FP | 1 |
Zeng, H | 1 |
Xie, N | 1 |
Zhong, L | 1 |
Liu, L | 1 |
Fang, Y | 1 |
Qi, X | 1 |
Cao, J | 1 |
Yang, B | 1 |
He, Q | 1 |
Ying, M | 1 |
Dos Santos, C | 1 |
Demur, C | 1 |
Bardet, V | 1 |
Prade-Houdellier, N | 1 |
Payrastre, B | 1 |
RĂ©cher, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia[NCT05042531] | 30 participants (Anticipated) | Interventional | 2021-11-13 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Synergistic effects of LY294002 and ABT199 on the cell cycle in K562, HL60 and KG1a cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; | 2021 |
Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Membe | 2013 |
Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells.
Topics: Androstadienes; Autophagy; Cell Differentiation; Cell Line, Tumor; Chloroquine; Chromones; Dasatinib | 2014 |
A critical role for Lyn in acute myeloid leukemia.
Topics: Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Chromones; Enzyme Inhibitors; Flow Cytometry; Humans | 2008 |